Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Abatacept
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Abatacept in Patients With Active Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE3
A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Abatacept in Patients With Active Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris
- Status
- COMPLETED
- Phase
- PHASE1
Comparability DE vs CD-CHO1
- Status
- COMPLETED
- Phase
- PHASE1
Islet Transplantation Using Abatacept
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Study of Abatacept in Combination With Etanercept
- Status
- COMPLETED
- Phase
- PHASE2
An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
- Status
- COMPLETED
- Phase
- PHASE2
Remission and Joint Damage Progression in Early Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone
- Status
- COMPLETED
- Phase
- PHASE2